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Background
Previously we demonstrated the differentiation pathway
of mouse, monkey and human ES cells to vascular cell
components [1-3]. In addition, we showed the therapeu-
tic potential of these ES-derived vascular cells. When
transplanted in mouse hind-limb ischemia model, these
cells were incorporated in host vessels in the ischemic
lesion and contributed to host neovascular formations
[4]. In these our studies, however, primary cultured
human adult vascular endothelial cells were not incorpo-
rated in host vessels and did not have same therapeutic
effect as ES-derived vascular endothelial cells (See Figure
1). In addition, ES-derived vascular endothelial cells had
higher viability against oxidative stress and higher ability
to re-endothelization in wound-healing model than adult
vascular endothelial cells. We supposed that ES-derived
young vascular endothelial cells have higher ability as the
cell source for vascular regeneration than adult aged vas-
cular endothelial cells. On the other hand, we previously
reported significance and therapeutic potential of the
natriuretic peptides/cGMP/cGMP-dependent protein
kinase pathway in vascular regeneration. Natriuretic pep-
tides (NP) significantly stimulated capillary network for-
mation of cultured endothelial cells by cGK stimulation
and subsequent Erk12 activation [5]. Therefore, we are
now investigating the difference of NO/cGMP and NP/
cGMP pathway between ES-derived vascular cells and
adult vascular cells. In addition, human induced pluripo-
tent stem (iPS) cells are a novel stem cell population
derived from human adult somatic cells through repro-
gramming using a defined set of transcription factors [6].
Our aim was to determine the features of the directed dif-
ferentiation of human iPS cells into vascular endothelial
cells and mural cells, and to compare that process with
human ES cells.
Results
We previously established a system for differentiating hES
cells into vascular cells. We applied this system to human
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Incorporated human ES-derived endothelial cells at the sites  of regeneration Figure 1
Incorporated human ES-derived endothelial cells at 
the sites of regeneration. A: Transplanted human ES-
derived endothelial cells in mouse ischemic hindlimbs were 
detected by fluorescence stereomicroscope. B: Transplanted 
human adult endothelial cells. Red: human CD31 Green: host 
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iPS cells and examined their directed differentiation. After
differentiation, TRA1-60- Flk1+ cells emerged and divided
into VE-cadherin-positive and -negative populations. The
former were also positive for CD34, CD31 and eNOS, and
were consistent with ECs. The latter differentiated into
MCs, which expressed smooth muscle -actin and cal-
ponin after further differentiation (See Figure 2). The effi-
ciency of the differentiation was comparable to that of
human ES cells. In addition, we compared the gene
expressions such as eNOS, CNP and CGK of human ES-
derived or human iPS-derived endothelial cells with those
of human adult endothelial cells to clarify the difference
of characters between them.
Conclusion
We succeeded in inducing and isolating human vascular
cells from iPS cells and indicate that the properties of
human iPS cell differentiation into vascular cells are
nearly identical to those of hES cells. We also compared
them with human adult endothelial cells in relation to the
difference of NO/cGMP and NP/cGMP pathway. This
work will contribute to our understanding of human vas-
cular differentiation/development and to the develop-
ment of vascular regenerative medicine.
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A, B: Immunostaining of human iPS-derived VEcadherin+ cells Figure 2
A, B: Immunostaining of human iPS-derived VEcadherin+ cells: red, CD31 (A) or eNOS (B) C, D: Immunostaining of 
human iPS-derived VEcadherin- Flk1+ cells for mural cell markers: C, SMA; D, calponin Scale bar: 50 m.